NASDAQ
PRE
Last Price
US $21.24
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Prenetics Global Limited cash flow to debt ratio of -989.61% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Prenetics Global Limited's free cash flow has increased -26.45% from $-29.94M last year to $-22.02M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Prenetics Global Limited's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Prenetics Global Limited's debt has decreased relative to shareholder equity from 0.03 last year to 0.00 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Prenetics Global Limited has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Prenetics Global Limited earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Prenetics Global Limited's profit margin has increased (-58.70%) in the last year from -151.22% to -62.45%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Prenetics Global Limited's short-term assets of $83.39M exceed its short-term liabilities of $27.67M
Decreasing performance - ROA.
Prenetics Global Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Prenetics Global Limited's return on equity of -46.74%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Prenetics Global Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Prenetics Global Limited had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Prenetics Global Limited has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Prenetics Global Limited has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Prenetics Global Limited's yearly earnings has increased -18.56% since last year from $-46.30M to $-37.71M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Prenetics Global Limited's yearly revenue has increased 201.72% since last year from $30.62M to $92.39M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -25.54% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Prenetics Global Limited's 3-year revenue CAGR of 91.46% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Prenetics Global Limited had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Prenetics Global Limited had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Prenetics Global Limited has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Prenetics Global Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Prenetics Global Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Prenetics Global Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Prenetics Global Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Prenetics Global Limited has a price-to-book ratio of 2.98x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Prenetics Global Limited has a price-to-sales ratio of 3.17x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-46.74%
Return on equity
ROIC: -25.54%
Valuation History
-3.9X
Price to Earnings
EV/EBITDA: -4.8X
Cash flow
Profit margin
-46.46%
(FY vs FY)
Cash flow Y/Y
-23.05%
(FY vs FY)
Fair Value
Market $21.24
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.